Search: WFRF:(Krysko DV)
> (2021) >
Novel porphyrazine-...
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
-
Turubanova, VD (author)
-
Mishchenko, TA (author)
-
Balalaeva, IV (author)
-
show more...
-
Efimova, I (author)
-
Peskova, NN (author)
-
Klapshina, LG (author)
-
Lermontova, SA (author)
-
- Bachert, C (author)
- Karolinska Institutet
-
Krysko, O (author)
-
Vedunova, MV (author)
-
Krysko, DV (author)
-
show less...
-
(creator_code:org_t)
- 2021-03-30
- 2021
- English.
-
In: Scientific reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 11:1, s. 7205-
- Related links:
-
https://www.nature.c...
-
show more...
-
http://kipublication...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy. Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is characterized by the emission of damage-associated molecular patterns (DAMPs) from dying cells. This emission can trigger effective anti-tumor immunity. Only a few photosensitizers are known to induce ICD and, therefore, there is a need for development of new photosensitizers that can induce ICD. The purpose of this work was to analyze whether photosensitizers developed in-house from porphyrazines (pz I and pz III) can induce ICD in vitro and in vivo when used in PDT. We indetified the optimal concentrations of the photosensitizers and found that, at a light dose of 20 J/cm2 (λex 615–635 nm), both pz I and pz III efficiently induced cell death in cancer cells. We demonstrate that pz I localized predominantly in the Golgi apparatus and lysosomes while pz III in the endoplasmic reticulum and lysosomes. The cell death induced by pz I-PDT was inhibited by zVAD-fmk (apoptosis inhibitor) but not by ferrostatin-1 and DFO (ferroptosis inhibitors) or by necrostatin-1 s (necroptosis inhibitor). By contrast, the cell death induced by pz III-PDT was inhibited by z-VAD-fmk and by the necroptosis inhibitor, necrostatin-1 s. Cancer cells induced by pz I-PDT or pz III-PDT released HMGB1 and ATP and were engulfed by bone marrow-derived dendritic cells, which then matured and became activated in vitro. We demonstrate that cancer cells, after induction of cell death by pz I-PDT or pz III-PDT, are protective when used in the mouse model of prophylactic tumor vaccination. By vaccinating immunodeficient mice, we prove the role of the adaptive immune system in protecting against tumours. All together, we have shown that two novel porphyrazines developed in-house are potent ICD inducers that could be effectively applied in PDT of cancer.
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Turubanova, VD
-
Mishchenko, TA
-
Balalaeva, IV
-
Efimova, I
-
Peskova, NN
-
Klapshina, LG
-
show more...
-
Lermontova, SA
-
Bachert, C
-
Krysko, O
-
Vedunova, MV
-
Krysko, DV
-
show less...
- Articles in the publication
-
Scientific repor ...
- By the university
-
Karolinska Institutet